Skip to main content
    B

    BridgeBio Pharma Inc (BBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $76.80
    -0.56 (-0.72%)

    Market Cap: $15.07B

    Last updated: Nov 17, 2026 at 4:23 PM ET

    BridgeBio Pharma Inc (BBIO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    BridgeBio Pharma (BBIO) has a latest price of $76.80 on Nov 17, 2026, 17.8% below its 52-week high of $93.42. Its price rose 15.7% over the past 12 months. The month-end price rose 51.8% over the 5 years through Oct 2026, a compound annual rate of 8.7%.

    Price Chart

    From Jun 2019 to Oct 2026, its highest month-end close was $80.09 in Jul 2026 and its lowest $6.83 in May 2022, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart BBIO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BBIO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 8.5%, and over 6 months it rose 16.4%. The month-end price rose 187.8% over the 3 years through Oct 2026, a compound annual rate of 42.2%.

    PeriodChange
    1 month+13.0%
    3 months-8.5%
    6 months+16.4%
    12 months+15.7%
    12 months, with dividends+15.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+187.8%+42.2%
    5 years+51.8%+8.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 429.8%, and its weakest was 2021, when it fell 76.5%.

    YearCloseChange
    2026 through Oct 2026$74.95-2.0%
    2025$76.49+178.8%
    2024$27.44-32.0%
    2023$40.37+429.8%
    2022$7.62-54.3%
    2021$16.68-76.5%
    2020$71.11+102.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 9.6% above its 50-day average of $70.07 and 5.7% above its 200-day average of $72.69.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$76.80
    52-week high$93.42-17.8%
    52-week low$62.50+22.9%
    50-day average$70.07+9.6%
    200-day average$72.69+5.7%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 49.1%.

    MeasureValue
    1-year beta0.95
    Largest fall, 1 year-29.8%
    Largest fall, 3 years-49.1%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About BBIO

    What is BBIO's 1-year price change?

    BridgeBio Pharma's price rose 15.7% over the past 12 months. With dividends included, the 12-month total return was 15.7%.

    What is BBIO's 5-year price change?

    BridgeBio Pharma's month-end price rose 51.8% over the 5 years through Oct 2026, a compound annual rate of 8.7%. These figures leave out dividends.

    What is BBIO's 52-week high and low?

    BridgeBio Pharma's 52-week high is $93.42 and its 52-week low is $62.50. Its latest price of $76.80 on Nov 17, 2026 is 17.8% below the high.

    What is BBIO's beta?

    BridgeBio Pharma's 1-year beta against the S&P 500 is 0.95, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 29.8%.

    Is the BBIO chart free?

    Yes. Advanced Charting for BBIO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.